This is a preview of subscription content, log in via an institution to check access.
Reference
Mason JM, et al. Ciclosporin compared to prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial. British Journal of Dermatology : 9 Apr 2017. Available from: URL: http://doi.org/10.1111/bjd.15561
Rights and permissions
About this article
Cite this article
Ciclosporin good choice for treatment of large PG lesions. PharmacoEcon Outcomes News 776, 10 (2017). https://doi.org/10.1007/s40274-017-3912-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3912-0